Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Losartan in Hypertensive Patients With IGT
NCT00407862Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of telmisartan in hypertension (HTN) and impaired glucose tolerance (IGT) (2 arms), sponsored by Medical University of Graz. Primary endpoints: Homeostasis Model Assessment Index at 3 months, Insulin Sensitivity Index at 3 months and 2 more. Started Jan 2005; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00407862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407862.